146 related articles for article (PubMed ID: 38238432)
1. Time to surgery is not an oncological risk factor in patients with cholangiocarcinoma undergoing curative-intent liver surgery.
Mantas A; Liu D; Otto CC; Heij LR; Heise D; Bruners P; Lang SA; Ulmer TF; Neumann UP; Bednarsch J
Sci Rep; 2024 Jan; 14(1):1644. PubMed ID: 38238432
[TBL] [Abstract][Full Text] [Related]
2. The prognostic role of in-hospital transfusion of fresh frozen plasma in patients with cholangiocarcinoma undergoing curative-intent liver surgery.
Bednarsch J; Czigany Z; Heij LR; Luedde T; Loosen SH; Dulk MD; Bruners P; Lang SA; Ulmer TF; Neumann UP
Eur J Surg Oncol; 2022 Mar; 48(3):604-614. PubMed ID: 34565633
[TBL] [Abstract][Full Text] [Related]
3. Time to surgery is not an oncological risk factor in HCC patients undergoing liver resection.
Otto CC; Wang G; Mantas A; Heise D; Bruners P; Lang SA; Ulmer TF; Neumann UP; Heij LR; Bednarsch J
Langenbecks Arch Surg; 2023 May; 408(1):187. PubMed ID: 37160788
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
6. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
[TBL] [Abstract][Full Text] [Related]
7. Impact of perioperative chemotherapy on survival in patients with cholangiocarcinoma undergoing curative resection.
Hassan H; Chakrabarti S; Zemla T; Yin J; Wookey V; Prasai K; Abdellatief A; Katta R; Tran N; Jin Z; Cleary S; Roberts L; Mahipal A
Eur J Surg Oncol; 2023 Nov; 49(11):106994. PubMed ID: 37524649
[TBL] [Abstract][Full Text] [Related]
8. Impact of preoperative endoscopic ultrasound-guided fine needle aspiration on postoperative recurrence and survival in cholangiocarcinoma patients.
El Chafic AH; Dewitt J; Leblanc JK; El Hajj II; Cote G; House MG; Sherman S; McHenry L; Pitt HA; Johnson C; Mohamadnejad M; Al-Haddad M
Endoscopy; 2013 Nov; 45(11):883-9. PubMed ID: 24165813
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
10. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors.
Wang Y; Zhu GQ; Zhou CW; Li N; Yang C; Zeng MS
Eur Radiol; 2022 Aug; 32(8):5166-5178. PubMed ID: 35316365
[TBL] [Abstract][Full Text] [Related]
12. The Presence of Small Nerve Fibers in the Tumor Microenvironment as Predictive Biomarker of Oncological Outcome Following Partial Hepatectomy for Intrahepatic Cholangiocarcinoma.
Bednarsch J; Tan X; Czigany Z; Liu D; Lang SA; Sivakumar S; Kather JN; Appinger S; Rosin M; Boroojerdi S; Dahl E; Gaisa NT; den Dulk M; Coolsen M; Ulmer TF; Neumann UP; Heij LR
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359564
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study.
Shen WF; Zhong W; Liu Q; Sui CJ; Huang YQ; Yang JM
World J Surg; 2011 Sep; 35(9):2083-91. PubMed ID: 21698503
[TBL] [Abstract][Full Text] [Related]
14. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
[TBL] [Abstract][Full Text] [Related]
15. Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study.
Zhang G; Chen BW; Yang XB; Wang HY; Yang X; Xie FC; Chen XQ; Yu LX; Shi J; Lu YY; Zhao HT
World J Gastroenterol; 2022 Nov; 28(41):5968-5981. PubMed ID: 36405111
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.
Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V
J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332
[TBL] [Abstract][Full Text] [Related]
17. Impact of cirrhosis on long-term survival outcomes of patients with intrahepatic cholangiocarcinoma.
Wang J; Qiu Y; Yang Y; Shen S; Zhi M; Zhang B; Wang W
Cancer Med; 2022 Oct; 11(19):3633-3642. PubMed ID: 35415945
[TBL] [Abstract][Full Text] [Related]
18. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
Wang X; Wang W; Ma X; Lu X; Li S; Zeng M; Xu K; Yang C
Eur Radiol; 2020 Oct; 30(10):5337-5347. PubMed ID: 32385649
[TBL] [Abstract][Full Text] [Related]
19. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
[TBL] [Abstract][Full Text] [Related]
20. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
[No Abstract] [Full Text] [Related]
[Next] [New Search]
